Pharmacoeconomic Analysis of Type 2 Diabetes Mellitus Patients with the Application of PGA (Use of Antimicrobials) at Hospital X in East Java

Authors

  • Nisvi Dewi Universitas Esa Unggul
  • Ratna Indrawati
  • Anastina Tahjoo

DOI:

https://doi.org/10.35654/ijnhs.v8i3.865

Keywords:

Type 2 Diabetes Mellitus, Pharmacoeconomics, Antimicrobial Resistance, Antimicrobial Use

Abstract

Background: Type 2 Diabetes Mellitus (T2DM) leads to a reduced immune response and increased susceptibility to infections, necessitating the use of antibiotics. However, inappropriate and excessive use of antimicrobials in humans, animals, and plants can contribute to increased antimicrobial resistance. Objective: This research aims to provide an overview of the application of Antibiotic Management (PGA) in the use of reserve antibiotics for T2DM patients concerning pharmacoeconomics at X Hospital in East Java. Method: Method: The study employed an observational approach with an exploratory descriptive method. Data were collected retrospectively from a cohort of patients who received reserve class antibiotics. The effectiveness of these antibiotics was assessed based on clinical outcomes, including patient survival or death, using medical records from October 2021 to September 2022 and October 2022 to September 2023. Result: The result indicated that the application of PGA using reserve antibiotics in T2DM patients had a positive and significant impact on pharmacoeconomics. The Incremental Cost Effectiveness Ratio (ICER) for T2DM patients with infections who received reserve antibiotics decreased after PGA implementation. Conclusion: The study concludes that PGA application in T2DM patients with infections yielded positive results, including a reduction in ICER, indicating improved cost-effectiveness and clinical outcomes. Recommendation: Proper and controlled use of reserve antibiotics through PGA can help mitigate antimicrobial resistance, a critical global health issue

Downloads

Download data is not yet available.

References

(1) Zhou K, Lansang MC. Diabetes Mellitus and Infection. [Updated 2024 Jun 30]. In: Feingold KR, Ahmed SF, Anawalt B, et al., editors. Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.; 2000–. Available from: https://www.ncbi.nlm.nih.gov/books/NBK569326/

(2) World Health Organization (WHO). Antimicrobial resistance. 2021. Available from: https://www.who.int/news-room/fact-sheets/detail/antimicrobial-resistance

(3) World Health Organization (WHO). Sekarang Saatnya Beraksi Menangkal Resistensi Antimikroba. 2022. Available from: https://www.who.int/indonesia/id/news/detail/12-10-2022-time-to-act-to-curb-antimicrobial-resistance-now

(4) Hadi U, Kuntaman K, Qibtiyah M, Paraton H. Audit of antibiotic prescribing in two governmental teaching hospitals in Indonesia. Clin Microbiol Infect. 2008 Jul;14(7):698–707. doi: 10.1111/j.1469-0691.2008.02014.x

(5) Menteri Kesehatan Republik Indonesia. Peraturan Menteri Kesehatan Republik Indonesia Nomor 2406/Menkes/Per/XII/2011 tentang Pedoman Umum Penggunaan Antibiotik. Jakarta: Kementerian Kesehatan RI; 2011.

(6) Martín-Timón I, Sevillano-Collantes C, Segura-Galindo A, Del Cañizo-Gómez FJ. Type 2 diabetes and cardiovascular disease: Have all risk factors the same strength? World J Diabetes. 2014 Aug 15;5(4):444–70. doi: 10.4239/wjd.v5.i4.444

(7) Ali J, Haider SMS, Ali SM, Haider T, Anwar A, Hashmi AA. Overall clinical features of type 2 diabetes mellitus with respect to gender. Cureus. 2023 Mar 4;15(3):e35771. doi: 10.7759/cureus.35771

(8) Mauvais-Jarvis F. Gender differences in glucose homeostasis and diabetes. Physiol Behav. 2018 Apr 1;187:20–3. doi: 10.1016/j.physbeh.2017.08.016

(9) Imelda S. Faktor-faktor yang mempengaruhi terjadinya diabetes di Puskesmas Harapan Raya tahun 2018 [Undergraduate thesis]. Pekanbaru: Universitas Riau; 2018.

(10) Galita TN, Septianingrum TD. Hormon dalam perspektif Islam. J Dev Res Educ. 2022;3(1):44–51.

(11) Ahmed GM, Abdelaziz HO, El Sayed HM, Adly MA. Histopathological changes on the kidney and lung of experimentally induced diabetic rats. Unpublished manuscript; 2023.

(12) Rohmatullah VR, Rizkiyah R, Parjianto B, Kinasih LS. Hubungan usia dan jenis kelamin terhadap angka kejadian diabetes melitus tipe 2 berdasarkan 4 kriteria diagnosis di poliklinik penyakit dalam RSUD Karsa Husada Kota Batu. Unpublished manuscript; 2024.

(13) Alkhalaf M, Al-Bustan S, Hamoda H, Abdella N. Polymorphism of p53 gene codon 72 in Kuwaiti with coronary artery disease and diabetes. Int J Cardiol. 2007 Jan 24;115(1):1–6. doi: 10.1016/j.ijcard.2006.03.055

(14) Mildawati M, Diani N, Wahid A. Hubungan usia, jenis kelamin dan lama menderita diabetes dengan kejadian neuropati perifer diabetik. Caring Nurs J. 2019;3(2):30–7. doi: 10.22219/cnj.v3i2.8812

(15) Arymbhi S, Asih J, Herleeyana M, Budiartha N, Triani Lestari K. Tren penggunaan antibiotik dan profil resistensi pada kelompok critical-priority bacteria di ICU Rumah Sakit “X” Provinsi Bali (2017–2019). Unpublished manuscript; 2023.

(16) Versporten A, Zarb P, Caniaux I, Gros MF, Drapier N, Miller M, et al. Antimicrobial consumption and resistance in adult hospital inpatients in 53 countries: results of an internet-based global point prevalence survey. Lancet Glob Health. 2018 Jun;6(6):e619–29. doi: 10.1016/S2214-109X(18)30186-4

(17) Hodo?an V, Daina CM, Zaha DC, Cotr?u P, Vladu A, Panti? C, et al. Pattern of antibiotic use in the perinatal period in a public university hospital in Romania. Medicina (Kaunas). 2022 Jun;58(6):77. doi: 10.3390/medicina58060777

(18) Pechijareva-Sadikarijo I, Naumovska Z, Petrovski O, Stavrikj K, Balkanov T. Antibiotic consumption in hospitalized children at the University Clinic for Pediatric Diseases–Skopje. Open Access Maced J Med Sci. 2020;8(E):405–10. doi: 10.3889/oamjms.2020.3569

(19) Francisco EM. Fluoroquinolone and quinolone antibiotics: PRAC recommends new restrictions on use following review of disabling potentially long-lasting side effects. European Medicines Agency. 2018. Available from: https://www.ema.europa.eu/en/news/fluoroquinolone-quinolone-antibiotics-prac-recommends-new-restrictions-use-following-review

(20) Sankar A, Swanson KM, Zhou J, Jena AB, Ross JS, Shah ND, et al. Association of fluoroquinolone prescribing rates with black box warnings from the US Food and Drug Administration. JAMA Netw Open. 2021 Dec 1;4(12):e2136662. doi: 10.1001/jamanetworkopen.2021.36662

(21) Wahyuningsih SA. Terapi thought stopping, relaksasi progresif dan psikoedukasi terhadap penurunan ansietas pasien GGK yang menjalani hemodialisa. J Keperawatan Silampari. 2020;3(2):648–60. doi: 10.31539/jks.v3i2.1094

(22) Karminingtyas SR, Oktianti D, Furdiyanti NH. Keefektifan penggunaan antibiotik profilaksis pada pasien bedah sesar (sectio caesarea). Cendekia J Pharm. 2018;2(1):22–31.

(23) Rahmayati E, Hardiansyah R, Nurhayati N. Pengaruh aromaterapi lemon terhadap penurunan skala nyeri pasien post operasi laparatomi. J Kesehatan. 2018;9(3):427. doi: 10.26630/jk.v9i3.1138

(24) Rosmawati E, Hartianty EP, Kurnia A, Mardiyanti S. Formulasi dan evaluasi sediaan granul mukoadhesif amoksisilin trihidrat dengan polimer kitosan. JFI Online. 2023;15(2).

(25) Tonin FS, Aznar-Lou I, Pontinha VM, Pontarolo R, Fernandez-Llimos F. Principles of pharmacoeconomic analysis: the case of pharmacist-led interventions. Pharm Pract (Granada). 2021 Jan-Mar;19(1):2173. doi: 10.18549/PharmPract.2021.1.2173

(26) Brent RJ. Cost-benefit analysis versus cost-effectiveness analysis from a societal perspective in healthcare. Int J Environ Res Public Health. 2023 Mar 6;20(5):4637. doi: 10.3390/ijerph20054637

(27) Garg R, Singh G, Kumar S, Verma M, Podder L, Ingle V, et al. Impact of an antimicrobial stewardship program on targeted antimicrobial therapy in a tertiary care hospital. Unpublished manuscript

Downloads

Published

2025-06-20

Most read articles by the same author(s)